Ambuja Cements (AMBUJACEM) — Financial Results

1 Financial Results 🔴 High Importance Neutral 📄 PDF

Ambuja Cements Limited announced unaudited consolidated financial results for Q3 and nine months ended December 31, 2025, approved by the Board on January 30, 2026. The company published financial extracts in Financial Express (English, all editions) and Gujarati language (Ahmedabad edition) on January 31, 2026, complying with SEBI Listing Regulations. Full results are available on the company website and stock exchange platforms.

2 Financial Results 🔴 High Importance Neutral 📄 PDF

Ambuja Cements Limited submitted an audio recording of its analysts/investors call discussing unaudited financial results for Q3 and nine-month period ended December 31, 2025. The company disclosed results for both standalone and consolidated operations via weblink on its investor relations portal. No specific financial metrics or operational performance data were detailed in this regulatory announcement.

📊 Stock Analysis — AMBUJACEM ✨ Ask AI About This

About Ambuja Cements Limited (AMBUJACEM)

Construction Materials · Cement & Cement Products · Listed on NSE

Market Cap: ₹1,07,215.34 Cr P/E: 23.3 ROE: 7.7% ROCE: 4.6%

View full AMBUJACEM stock details →

📡 Get AI alerts when AMBUJACEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMBUJACEM — Free

💡 Ask AI about this filing

"How does this financial results affect Ambuja Cements Limited's outlook?" "What did Ambuja Cements Limited announce on 31 January 2026?" "Is this positive or negative for AMBUJACEM?"

Ask AI Free →

📊 More AMBUJACEM filings

See all AMBUJACEM filings →

🔥 Also filed on 31 January 2026

DELHIVERY Delhivery Limited Financial Results DELHIVERY Delhivery Limited Announcement SUNPHARMA Sun Pharmaceutical Industries Limited Corporate Action WIPRO Wipro Limited Corporate Action SUNPHARMA Sun Pharmaceutical Industries Limited Financial Results DELHIVERY Delhivery Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMBUJACEM files new disclosures

Track AMBUJACEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.